Blueprint vs Idexx Laboratories
Side-by-side comparison of AI visibility scores, market position, and capabilities
Clinical measurement and therapy outcomes platform for mental health providers, Austin TX, raised $8M+. Automates outcome tracking and progress notes for therapists.
About
Blueprint is an Austin, Texas-based clinical technology company founded in 2018 that provides mental health providers with a measurement-based care platform designed to automate outcomes tracking, streamline progress note documentation, and improve the quality and consistency of mental health treatment. The company has raised over $8 million and serves thousands of therapists and group practices seeking to implement structured clinical measurement without significant workflow disruption.\n\nBlueprint's platform automates the collection of validated clinical questionnaires (such as PHQ-9, GAD-7, and PCL-5) before or between sessions, presents clinicians with outcome trend visualizations at the point of care, and generates draft progress notes based on session data. The AI-assisted note generation feature is particularly valued by clinicians who spend significant time on documentation after sessions, with Blueprint reducing note completion time while improving clinical documentation quality and compliance.\n\nThe company distributes through direct sales to individual therapists and group practices, and is expanding partnerships with group practice management platforms and EHR vendors to embed its measurement capabilities into existing clinical workflows. Blueprint competes with Greenspace Health and Osmind in the measurement-based care space, and with Nabla and Heidi Health in the AI-assisted clinical documentation market. The intersection of outcomes accountability and administrative relief positions Blueprint as both a quality improvement tool and a therapist burnout reduction solution.
Veterinary diagnostics leader with $3.81B FY2024 revenue; 130,000+ analyzer installed base; AI-powered inVue Dx digital cytology; VetConnect data platform; pet humanization tailwind.
About
IDEXX Laboratories is the global leader in veterinary diagnostics and information technology for companion animal healthcare, founded in 1983 by David Shaw in Westbrook, Maine, where it remains headquartered. The company trades on Nasdaq (IDXX) and reported $3.81 billion in revenues for FY2024, maintaining its dominant position in point-of-care veterinary diagnostics through an installed base of over 130,000 Catalyst chemistry analyzers, ProCyte hematology systems, and SNAP rapid assay devices deployed in veterinary clinics worldwide. CEO Jay Mazelsky has continued IDEXX's expansion into AI-powered diagnostics and digital pathology, building on over four decades of veterinary-specific product development.
AI Visibility Head-to-Head
Key Details
Capabilities & Ecosystem
Capabilities
Also Compare
Track AI Visibility in Real Time
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.